6th March is European Swallowing Awareness Day

Posted under Fundraising, Patient Care, Research, Supporters on

Today, 6th March is European Swallowing Awareness Day. Research has shown that up to 60% of patients suffer from swallowing difficulties following treatment for head and neck cancer which is a serious issue as numbers of new cases are increasing at a relentless rate. Oracle Cancer Trust have funded significant research projects to reduce issue […]

2016 Supporter Research Event

Posted under Fundraising, Newsletter, Patient Care, Supporters on

Over 60 supporters joined the team of Oracle researchers and staff to hear about the latest innovations in head and neck cancer projects funded by Oracle Cancer Trust.  The event was held in mid-October at The ICR in Fulham Road and supporters heard presentations by Oracle funded project leaders Professor Caroline Springer, Professor Uwe Oelfke, Dr Imran Petkar and […]

Immunotherapy drug for treating HPV+ head and neck cancers hailed as “game-changer”

Posted under Fundraising, Newsletter, Patient Care, Research, Supporters on

A new generation of “game-changing” drugs that harness the body’s immune system have been found to extend the lives of head and neck cancer sufferers.  The drug, Nivolumab, resulted in the doubling of one-year survival rates in clinical trials on HPV+ head and neck cancer patients.  Findings will be presented to the European Society for […]

Oracle-funded study improves treatment prospects for cancer patients

Posted under Newsletter, Patient Care, Research, Supporters on

Read the ICR’s latest blog post about the success of our recent Oracle-funded study into combining radiotherapies with viruses to improve treatment prospects for cancer patients. Oracle-funded scientists at the ICR and The Royal Marsden NHS Foundation Trust combined the oncolytic reovirus RT3D, with radiotherapy to treat melanoma, and found that the combination was much […]

Summer 2016 Newsletter

Posted under Fundraising, Newsletter, Patient Care, Supporters on

The Oracle Summer 2016 Newsletter is now available to download.  Features in this issue include research updates from our team of funded head and neck cancer researchers, remedy stories from our fantastic fundraisers who have taken on some great physical challenges to support Oracle, try and patients who have kindly shared their experiences of their diagnosis and treatment […]

HPV Positive Patient Hayley shares her story

Posted under Fundraising, Newsletter, Patient Care, Supporters on

Hayley Mugadzaweta, 36, of Buckinghamshire shared her story recently in the popular womens weekly magazine, Take a Break. HPV positive oropharyngeal cancers (these areas include the base of the tongue, the tonsils, the soft palate, and the walls of the pharynx) are one of the fastest growing groups of head and neck cancers that are increasingly affecting […]

New MR Linac Machine taking shape

Posted under Newsletter, Patient Care, Research, Supporters on

New revolutionary radiotherapy machine, thumb MR Linac, salve is taking shape at The Royal Marsden Hospital in Sutton following delivery of a giant magnet. Oracle is funding two PhD students on this pioneering project to study its use with treating head and neck cancer patients. Says Professor Kevin Harrington “Radiation plays a central role in […]

Experimental virus therapy cures Oracle Board Member Sir Michael Lockett

Posted under Fundraising, Newsletter, Patient Care, Research, Supporters on

Sir Michael Lockett took part in a trial under the care of Professor Kevin Harrington using a cold sore virus therapy that cured his head and neck cancer.  Read more in the article that appeared in The Mail on Sunday. http://www.dailymail.co.uk/health/article-3602308/How-cold-sore-virus-killed-cancer-mastermind-London-s-2012-Olympics-reveals-injections-herpes-virus-vaccinated-against-future-tumours.html

New head and neck cancer drug “game changer”

Posted under Fundraising, Newsletter, Patient Care, Research, Supporters on

A new type of cancer drug that wakes up the patient’s own immune system to fight tumours could be a game changer for tackling aggressive head and neck cancers, say experts. The news announced today, 19th April at a conference supports the work of Professor Kevin Harrington.  Read the full news report here.   http://www.bbc.co.uk/news/health-36081336

Oracle feature in The Daily Mail about Tonsillar Cancer

Posted under Fundraising, Newsletter, Patient Care, Supporters on

Oracle’s voluntary CEO, Anthony Sykes appeared in The Daily Mail recently and shared his experiences of a swelling on his neck being diagnosed as tonsillar cancer, which was successfully treated following surgery, chemotherapy and one month of radiotherapy. Read the full article here: http://www.dailymail.co.uk/health/article-3427330/Are-throat-cancers-rise-ve-stopped-taking-tonsils-out.html

#UnitingVoices campaign to raise awareness of head and neck cancer

Posted under Fundraising, Patient Care, Research, Supporters on

The European Head and Neck Society have launched a new campaign “Make Sense”.  The campaign aims to raise awareness of the disease through greater education of the signs and symptoms to promote earlier diagnosis and referral, abortion with the ultimate aim of improving patient outcomes. Head and Neck cancer is a preventable disease, rx and […]